ATC B05AA01 · Blood Substitutes and Perfusion Solutions
Albumin shortage
As of 31 Oct 2026, Albumin has a reported shortage in 4 of the 5 countries we track (Italy, Spain, Austria, Belgium), covering 20 products.
Countries4/5
Products20packs or presentations
Short since1 Feb 20215.7 years ago
Earliest return31 Dec 2026company estimate
No return date6products
Main reasonIncreased demand
Timeline
ItalySpainAustriaBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | ALBUMINA BAXALTA | BAXALTA INNOVATIONS GMBH | 1 Apr 2021 | not given | Increased demand Elevata richiesta: forniture discontinue (carenza relativa solo al canale retail) |
| IT | ALBUMINA BAXALTA | BAXALTA INNOVATIONS GMBH | 1 Apr 2021 | not given | Increased demand Elevata richiesta: forniture discontinue |
| IT | ALBIOMIN | BIOTEST PHARMA GMBH | 15 Mar 2022 | 31 Dec 2026 | Distribution or logistics Ridotta disponibilità per forniture discontinue: distribuzione contingentata |
| IT | ALBUMINA GRIFOLS | INSTITUTO GRIFOLS S.A. | 20 Apr 2022 | 31 Dec 2026 | Increased demand Elevata richiesta: forniture discontinue (carenza relativa solo al canale ospedaliero) |
| IT | ALBUMINA GRIFOLS | INSTITUTO GRIFOLS S.A. | 20 Apr 2022 | 31 Dec 2026 | Increased demand Elevata richiesta: forniture discontinue (carenza relativa solo al canale ospedaliero) |
| IT | ALBUTEIN | GRIFOLS ITALIA S.P.A. | 20 Apr 2022 | 31 Dec 2026 | Increased demand Elevata richiesta: forniture discontinue (carenza relativa solo al canale ospedaliero) |
| IT | PLASBUMIN | INSTITUTO GRIFOLS S.A. | 20 Apr 2022 | 31 Dec 2026 | Increased demand Elevata richiesta: forniture discontinue (carenza relativa solo al canale ospedaliero) |
| IT | UMAN ALBUMIN | KEDRION S.P.A. | 13 May 2022 | not given | Increased demand Elevata richiesta: forniture discontinue |
| IT | ALBUMINA LFB | LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES | 1 Oct 2025 | 31 Dec 2026 | Manufacturing problem Problemi produttivi (carenza relativa solo al canale ospedaliero) |
| IT | ALBUMINA UMANA GRIFOLS | INSTITUTO GRIFOLS S.A. | 31 Oct 2025 | not given | Manufacturing problem Problemi produttivi: distribuzione contingentata |
| IT | UMAN ALBUMIN | KEDRION S.P.A. | 21 Nov 2025 | not given | Commercial decision or withdrawal Motivi commerciali |
| IT | ALBUMINA UMANA GRIFOLS | INSTITUTO GRIFOLS S.A. | 9 Mar 2026 | not given | Manufacturing problem Problemi produttivi: distribuzione contingentata |
| ES | ALBUMINA HUMANA CSL BEHRING 200 G/L SOLUCION PARA PERFUSION , 1 vial de 50 ml | Csl Behring Gmbh | 14 Apr 2024 | 29 Jun 2027 | Not stated |
| AT | Human Albumin “CSL Behring” 20% Infusionslösung, 100 ml | CSL Behring GmbH | 5 Sep 2025 | 30 Sep 2027 | Increased demand Unzureichendes Kontingent für Österreich |
| AT | Human Albumin “CSL Behring” 20% Infusionslösung, 50 ml | CSL Behring GmbH | 5 Sep 2025 | 30 Sep 2027 | Increased demand Unzureichendes Kontingent für Österreich |
| BE | Albunorm 20 % inf. sol. i.v. vial 100 ml | Octapharma Benelux | 1 Feb 2021 | 30 Sep 2030 | Other Other reason |
| BE | Albunorm 20 % inf. sol. i.v. vial 50 ml | Octapharma Benelux | 1 Feb 2021 | 30 Sep 2030 | Other Other reason |
| BE | Albunorm 5 % inf. sol. i.v. vial 100 ml | Octapharma Benelux | 1 Feb 2021 | 30 Sep 2030 | Other Other reason |
| BE | Albunorm 5 % inf. sol. i.v. vial 250 ml | Octapharma Benelux | 1 Feb 2021 | 30 Sep 2030 | Other Other reason |
| BE | Albunorm 5 % inf. sol. i.v. vial 500 ml | Octapharma Benelux | 1 Feb 2021 | 30 Sep 2030 | Other Other reason |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.